e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension
Rebecca R. Vanderpool, Ankit A. Desai, Shannon M. Knapp, Marc A. Simon, Aiden Abidov, Jason X.-J. Yuan, Joe G.N. Garcia, Lillian M. Hansen, Steven R. Knoper, Robert Naeije, Franz P. Rischard
Source:
Eur Respir J, 50 (2) 1700764; 10.1183/13993003.00764-2017
Journal Issue:
August
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rebecca R. Vanderpool, Ankit A. Desai, Shannon M. Knapp, Marc A. Simon, Aiden Abidov, Jason X.-J. Yuan, Joe G.N. Garcia, Lillian M. Hansen, Steven R. Knoper, Robert Naeije, Franz P. Rischard. How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension. Eur Respir J, 50 (2) 1700764; 10.1183/13993003.00764-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Bosentan combined with sildenafil prevents right ventricular hypoxia in pulmonary arterial hypertension
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
Upfront combination therapy reduces right ventricular volumes in pulmonary arterial hypertension
Source: Eur Respir J, 49 (6) 1700007; 10.1183/13993003.00007-2017
Year: 2017
Lodenafil improves hemodynamics and right ventricular remodeling in monocrotaline-induced model of pulmonary arterial hypertension in rats
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010
Effect of sitaxentan on haemodynamics and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension (PAH)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008
Improved right ventricular function after substantial afterload reduction in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012
Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012
Right ventricular stiffness impairs right atrial function in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020
Right ventricular and pulmonary vascular interaction in pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases
Year: 2008
Association of renal dysfunction with cardiac output and right atrial pressure in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
Macitentan in pulmonary hypertension due to left ventricular dysfunction
Source: Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017
Year: 2018
Impaired right ventricular lusitropy is associated with ventilatory inefficiency in pulmonary arterial hypertension
Source: Eur Respir J, 54 (5) 1900342; 10.1183/13993003.00342-2019
Year: 2019
Inhaled iloprost for patients with pulmonary arterial hypertension and right heart failure
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2013; 41: 224-232
Year: 2013
Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
The right ventricle in pulmonary arterial hypertension
Source: Eur Respir Rev 2014; 23: 476-487
Year: 2014
Sequential analysis of right ventricular function and exercise capacity in pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept